Showing results (161-170 of 259) with videos related to
Sort By:
Pageof 26
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 14, 2007
Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effectsKatrin M Kirschbaum, Matthias J Müller, Jaroslav Malevani, et al.Psychiatry Research|October 31, 2008
No effect of six weeks of treatment with escitalopram on mood in healthy volunteers--irrespective of genotype for the promoter of the serotonin transporterMichael Kellner, Cüneyt Demiralay, Christoph Muhtz, et al.International Clinical Psychopharmacology|May 17, 2019
Cytochrome P450-mediated inhibition of venlafaxine metabolism by trimipramineChristoph Kowalewski, Ekkehard Haen, Christoph Hiemke, et al.European Archives of Psychiatry and Clinical Neuroscience|April 6, 2021
Clinical response in patients treated with once-monthly paliperidone palmitate: analysis of a therapeutic drug monitoring (TDM) databaseGeorgios Schoretsanitis, Ekkehard Haen, Daria Piacentino, et al.Therapeutic Drug Monitoring|July 22, 2008
Large variability of aripiprazole and dehydroaripiprazole serum concentrations in adolescent patients with schizophreniaChristian J Bachmann, Anette Rieger-Gies, Monika Heinzel-Gutenbrunner, et al.Journal of Psychopharmacology (Oxford, England)|February 6, 2021
Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesisMaxim Kuzin, Ekkehard Haen, Christoph Hiemke, et al.Expert Review of Clinical Pharmacology|December 17, 2021
Effects of body weight, smoking status, and sex on plasma concentrations of once-monthly paliperidone palmitateGeorgios Schoretsanitis, Ekkehard Haen, Daria Piacentino, et al.Pharmacology, Biochemistry, and Behavior|April 25, 2012
In vitro P-glycoprotein efflux inhibition by atypical antipsychotics is in vivo nicely reflected by pharmacodynamic but less by pharmacokinetic changesUlrich Schmitt, Katrin M Kirschbaum, Birk Poller, et al.Journal of Neuroscience Research|April 11, 2009
Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stressOlaf Schulte-Herbrüggen, Eberhard Fuchs, Nashat Abumaria, et al.Pharmacology Research & Perspectives|February 24, 2023
Lower sertraline plasma concentration in patients co-medicated with clozapine-Implications for pharmacological augmentation strategies in schizophreniaArnim Johannes Gaebler, Ekkehard Haen, Nagia Ben Omar, et al.Pageof 26